Global Vascular Patch Market 2020 (Includes Business Impact of COVID-19)

                                          
“Global Vascular Patch Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by Trusted Business Insights. The global vascular patch market report has been segmented on the basis of material, application, end user, and region.

Request Covid - 19 Impact


Global Vascular Patch Market: Overview

Vascular Patch is manufactured from a polymer material such as polyestherurethane, which have maximum mechanic long-term stability and excellent biocompatibility. The vascular patch is used in a wide range of cardiovascular applications including great vessel, cardiac, and peripheral vascular reconstructions.

Global Vascular Patch Market: Dynamics

The key factor driving the growth of the target market is increasing aging population across the globe. According to data published by World Population Prospects, the aging persons (above 60 years or over), is expected to reach about 2.1 billion by 2050.

In addition, growing incidences of cardiovascular diseases, increasing number of surgeries, and growing demand for effective and minimal invasive treatment procedures are some factors expected to drive the income growth of the target market.

Furthermore, the government are spending high on healthcare in order to develop technologically advanced products and increasing adoption of biological patches are another factor likely to increase demand for vascular patch worldwide.

However, products recalls and high cost are the factors restraining the growth of the target market to a certain extent.

Global Vascular Patch Market: Segment Analysis

On the basis of material, biologic vascular patches segment is projected to accounts for large share, owing to advantages of biological patches such as least suture line bleeding and high biocompatibility compared to synthetic patches.

Global Vascular Patch Market: Trends

A key trend observed in the market currently is, many prominent players are focusing on getting FDA or EU approval for various other applications. For instance, in April 2018, Cardiva Medical, Inc., which is a US-based medical device company, received FDA approval for VASCADE VCS for use in arterial closure and femoral venous closures.

Global Vascular Patch Market: Regional Analysis

In 2017, the market in North America is accounted for highest market share of the vascular patch market. The rapidly growing prevelance of vascular disses and increasing geriatric population are the factors driving the growth of the market in countries in the region. Asia Pacific accounted for fastest growing CAGR, due to government initiatives and higher health care spending of patients in the region.

Global Vascular Patch Market Segmentation:

Segmentation by material

Biologic Vascular Patches
Synthetic Vascular Patches

Segmentation by application

Carotid Endarterectomy
Open Repair of Abdominal Aortic Aneurysms
Vascular Bypass Surgery
Other Applications

Segmentation by end user

Hospitals & Clinics
Ambulatory Surgical Centers